Tristel Share Discussion Threads

[tmfmayn] 17/2/2016 16:02

I wonder if the upcoming results presentation will update us on TSTL's view of its market.

The annual results presentation given in Oct 2014 said the instrument decontamination market (i.e. not surface disinfectants) into which TSTL then sold was valued at the time at £91m.

That £91m figure was based on 15.6m annual procedures in Western Europe, 15.5m in China/Hong Kong, 1m in Russia and 460k in Australasia, and each procedure being worth £2.80.

Would be useful to know if any of those figures have changed.

[tmfmayn] 17/2/2016 15:54

Piedro -- do you think it would benefit us ordinary shareholders if Soler stepped down again from the chairmanship?

His return to the chair has certain coincided with a more upbeat results narrative, with RNS references appearing about revenue/margin targets and progress for a USA product.

True, he was non-exec chair when the business began to stumble a few years ago, but Mr Swinney surely has to share any blame going for that setback.

Soler owns close to 30% of the shares, his bio suggests he likes to sell businesses and it's not clear to me that bringing in a fresh non-exec chairman is going add much more to our cause. What have I missed?

[piedro] 17/2/2016 15:21

As question time nears, a brief quote from the 2014 Annual Report...

Board change
Having served on the Board for three years, and with the business in both good health and capable hands, I feel it is the appropriate time for me to hand over the reins to a successor. I shall be stepping down from my role as Non-Executive Chairman on the 15th of October. The Board has begun a search for a new Non-Executive Chairperson, and in the meantime my predecessor Francisco Soler will take over the role on an interim basis.

I have written to Paul Swinney suggesting an announcement ...

[piedro] 08/2/2016 16:46

A tweat from Spain ...

[piedro] 04/2/2016 10:47

ProFormance™ Cleaning Verification - EndoCheck

Clean Inside a Scope with EndoCheck™
Flexible endoscopes are notoriously difficult to clean. More difficult still is verifying that the cleaning has been adequate. Now there is a test for checking the cleanliness of the biopsy channel of the flexible endoscope. The EndoCheck™ is a miniature chemistry kit that is simple to use and interpret. Simply swab the biopsy channel of the scope with the included soft-tipped long probe, clip off the swab into the vial. Mix the activating agent, shake vigorously, wait and then check for a color change. Depending on the type of test used, a color change indicates that blood residue or protein residue remains in the channel, and should be reprocessed.

[source] 28/1/2016 14:07

Nice strength recently looks like it wants to get back into its earlier initial higher range in the 140's?...IMHO.

Regards,
Source.

[source] 27/1/2016 15:16

Me too! :) was looking to add to my existing but glad to see its strength. Regards,Source.

[az4hr] 27/1/2016 14:30

Nice recovery from 115p missed my chance

[source] 26/1/2016 09:46

This year Tristel needs to have good newflow to keep its solid record from the last 4 years or so going. It luckily has a lot of irons in the fire though, any one of which, could do the job (hopefully)...

Regards,
Source.

[mach100] 26/1/2016 09:22

I will be there too, Having attended past presentations I must say I find Paul and Liz very honest and approachable. Hopefully the run of good news will continue.

[apad] 26/1/2016 08:48

I envy you both. I look forward to hearing your views. red, on VLG, made some very amusing comments on the MARS directors - I guess you don't see this unless you go.
apad

[source] 25/1/2016 22:49

Hopefully see you there then. Actually Tristel have been doing this for a number of years. They should be commended for their good equal treatment of PI's over the years (both with good and bad news over the years in my experience).

Regards,
Source.

[effortless cool] 25/1/2016 20:37

I'm impressed that they are doing a briefing for all investors as well as the analyst briefing. Even better, it's in a sensible place at a sensible time. I will be going.

Investor results briefing
A briefing for all investors will take place on Thursday 25 February at No.1 Cornhill, London, EC3V 3ND from 5.30pm for a 5.45pm start, and will be followed by drinks and canapés.

[piedro] 21/1/2016 12:19

Hand hygiene in the NHS: Parliament debates
Yesterday afternoon, a debate was scheduled in to take place in Westminster Hall on the motion: 'This House has considered hand hygiene in the NHS'. The debate was tabled by Nigel Mills MP, who has a keen interest in healthcare and hygiene issues. ... ...
hxxp://www.thecleanzine.com/pages/10800/hand_hygiene_in_the_nhs_parliament_debates/

[apad] 19/1/2016 15:46

EC,
You must be young, or you wouldn't make such a fundamental mistake :-)
It's only death the changes habits.
apad

[piedro] 19/1/2016 14:18

Options @65p on "change of control" of the Company
Paul Swinney...... 500,000
Elizabeth Dixon.... 87,500
Paul Barnes........ 87,500

[tmfmayn] 19/1/2016 14:14

Soler's bio in the annual report refers to selling 3 previous businesses he was involved in. The execs also have options that can be exercised only on a change of control, most of which expire in Oct 2019. Overall, I suspect a decent bid here will one day be the end game.

[effortless cool] 19/1/2016 13:44

Soler is 68, so could be willing to cash out to a decent offer.

[piedro] 19/1/2016 13:22

FYI,

Director & Substantial Shareholdings
- from website, updated to include latest Director purchase

Director Shareholdings..................Ord shares......%..
Paul Swinney...............................920,000....2.20%
Elizabeth Dixon.............................50,000....0.11%
Francisco Soler.........................10,624,988...25.58%
Paul Barnes................................700,180....1.69%
............................TOTAL.......12,295,168...29.58%

Substantial Shareholdings
Barclays Stockbrokers (EO)...............2,781,526....6.70%
Hargreaves Lansdown Stockbrokers (EO)....3,054,319....7.35%
Amarti Global Investors..................1,843,046....4.44%
Unicorn Asset Management.................1,635,629....3.94%
TD Waterhouse Stockbrokers (EO)..........1,351,248....3.25%
Self Trade Stockbrokers(EO)..............1,315,790....3.17%
............................TOTAL.......11,981,558...28.85%

......................GRAND TOTAL.......24,276,726...58.43%

[tromso1] 18/1/2016 15:59

"There is also a possibility of Tristel becoming a bid target as undoubtedly a fast growing cash rich and highly profitable company selling high-margin patented chlorine dioxide technology infection control healthcare products would represent a decent bolt-on purchase for a larger rival. In the circumstances, I would run your bumper gains."

[apad] 18/1/2016 13:15

Excellent timing EC, unlike the directors :-)
I increased this morning.
apad

[effortless cool] 18/1/2016 12:08

I view TSTL as back to a more appropriate price now, so this morning I have bought back the 20,000 shares that I sold on 17 December.